Metabasis Therapeutics, Inc. to Host Conference Call and Live Webcast to Discuss Second Quarter 2007 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics, (NASDAQ:MBRX), a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of metabolic and liver diseases by targeting the liver and liver pathways, announced today that it will host a conference call and live webcast on Thursday, August 2, 2007 at 1:30 p.m. Pacific Time to discuss its financial results for the second quarter of 2007. Dr. Paul Laikind, president and chief executive officer and Mr. John Beck, senior vice president of finance and chief financial officer, will participate in the call.

MORE ON THIS TOPIC